Biogen Inc. (NASDAQ:BIIB) shares increased 0.91% in last trading session and ended the day at $261.40. BIIB Gross Margin is 88.50% and its has a return on assets of 19.60%. Biogen Inc. (NASDAQ:BIIB) quarterly performance is -6.47%.
Standpoint Research began coverage on shares of Biogen Inc (NASDAQ:BIIB) in a report released on Thursday, The Fly reports. The brokerage issued a buy rating and a $360.00 price target on the biotechnology company’s stock.
PACCAR Inc. (NASDAQ:PCAR) ended the last trading day at $50.90. Company weekly volatility is calculated as 3.08% and price to cash ratio as 5.33. PACCAR Inc. (NASDAQ:PCAR) showed a weekly performance of 5.40%.
PACCAR Inc (NASDAQ:PCAR) declared a quarterly dividend. Shareholders of record on Friday, February 12th will be paid a dividend of 0.24 per share on Thursday, March 3rd. This represents a $0.96 dividend on an annualized basis and a yield of 1.92%. The ex-dividend date is Wednesday, February 10th. This is a positive change from PACCAR’s previous quarterly dividend of $0.20.
On 19 February, EQT Corporation (NYSE:EQT) shares moved down -3.33% and was closed at $58.89. EQT EPS growth in last 5 year was -18.60%. EQT Corporation (NYSE:EQT) year to date (YTD) performance is 13.03%.
EQT Corporation (NYSE:EQT) announced that it intends to commence a registered public offering of 6,500,000 shares of common stock, subject to market conditions. The Company also expects to grant the underwriter an option to purchase up to 975,000 additional shares of common stock. The Company intends to use net proceeds from this offering for general corporate purposes, which may include, among other things, repayment of a portion of its outstanding indebtedness.
Newmont Mining Corporation (NYSE:NEM) shares moved down -0.92% in last trading session and ended the day at $24.84. NEM Gross Margin is 45.80% and its has a return on assets of 1.90%. Newmont Mining Corporation (NYSE:NEM) quarterly performance is 47.35%.
Newmont Mining Corporation (NYSE:NEM) reported a little more than 5 million oz of gold production. All-in sustaining costs (AISC) were lowered by 10% to $898/oz. The largest U.S.-based gold miner completed the Turf Vent Shaft and reported that other projects were progressing on time and under budget.
CTI BioPharma Corp. (NASDAQ:CTIC) caters to the Healthcare space. Its weekly performance is 96.31%. On the last day of trading company shares ended up at $0.63. CTI BioPharma Corp. (NASDAQ:CTIC) distance from 50-day simple moving average (SMA50) is -3.68%.
On 10 February, CTI BioPharma Corp. (NASDAQ:CTIC) provided an update regarding the clinical studies being conducted under the Company’s Investigational New Drug (“IND”) application for pacritinib.
Leave a Reply